2024
Blood type as a risk factor for pancreatic ductal adenocarcinoma.
Rahimi Larki N, Skanderson M, Tate J, Levinson R, Hauser R, Brandt C, Yang Y, Justice A, Wang L. Blood type as a risk factor for pancreatic ductal adenocarcinoma. Journal Of Clinical Oncology 2024, 42: 10559-10559. DOI: 10.1200/jco.2024.42.16_suppl.10559.Peer-Reviewed Original ResearchPancreatic ductal adenocarcinoma riskVeterans Health AdministrationRisk of pancreatic ductal adenocarcinomaNon-O blood typeNeighborhood-level socioeconomic dataIntegrated healthcare systemHigh risk of pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaAssociated with higher riskAssociated with increased riskUnited StatesHealth AdministrationOutpatient encountersHealthcare systemBaseline ageAlcohol useIndex dateAssociation of blood typeCancer deathWhite populationSocioeconomic dataBlack patientsDiverse populationsRisk factorsBlood type
2022
Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care
Kidwai-Khan F, Rentsch C, Pulk R, Alcorn C, Brandt C, Justice A. Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient care. Frontiers In Big Data 2022, 5: 1059088. PMID: 36458283, PMCID: PMC9705957, DOI: 10.3389/fdata.2022.1059088.Peer-Reviewed Original ResearchK-Nearest NeighborSupport vector machinePreventable adverse eventsDecision support mechanismAdverse eventsCurrent medicationsExtreme gradient boostingPredictive modelingSoftware interfaceMachine learningVeterans AffairsData integrationF1 scoreLarge integrated healthcare systemNearest NeighborPatient's current medicationsVector machineOutpatient clinic visitsRandom forestDecision treeGradient boostingAUC scoreComplex treatment decisionsEHR dataIntegrated healthcare system